Company Overview and News
A largely volatile day has come to a close, with indices ending the day on a negative note. However, they are off the day’s low points. The Nifty has managed to give up 11,200 in today’s trade. The Sensex has closed over 200 points lower.
BHRYY 532617 511288 535789 534816 INFRATEL LHFLY 500253 GRAVITA SBAZ GRUH YESBANK KMBKY 511072 533282 IDKQY JETAIRWAYS GRHFY 532648 YYBKY IBULHSGFIN DHFL LICHSGFIN KOTAKBANK 500247
The Indian benchmark indices including the Sensex and the Nifty have turned red this Friday afternoon with the Nifty50 down 165 points and is trading at 11,069 while the Sensex has plunged 500 points at 36,621.
IOC PWQFY 500325 FEDA 532712 532832 531500 539437 535789 RCOM 532483 FEDS BJJQY GAILF 500570 BEL FEDERALBNK EICHERMOT RLNIY ASHOKLEY RAJESHEXPO BHQRY AXB RELCAPITAL 511072 JETAIRWAYS CANFINHOME FDBAY YYBKY 511196 530965 AKLD JSWSTEEL CNRYY 500182 AXBA DHFL BAJFINANCE GAILY KOTAKBANK MAX CANBK AKLS 506401 MXGQY IBREALEST 532939 500469 533150 500228 RELIANCE 532617 533273 KTKBANK 532810 532215 533106 DEEPAKNI 505200 500271 IDFCBANK 532461 OIL AXISBANK RIGD HEROMOTOCO 500477 TATAMOTORS 500034 500111 YESBANK RPOWER ECQRY KMBKY IDKQY 532648 AXBKY IBULHSGFIN PFC 532652 OBZIY GODREJPROP OBEROIRLTY PNJZY PNB HRTQY 500247 500049 TTM
The Indian stock market have turned weak and is trading flat this Friday afternoon with the Nifty50 down 16 points and is trading at 11,217 while the Sensex is trading higher by 20 points at 37,141.
IOC 500325 JIPKY 532514 535789 IGL JUSTDIAL 532483 534816 SONATSOFTW 500696 GAILF BEL RLNIY SBAZ BHQRY AXB 533282 JETAIRWAYS YYBKY 530965 JSWSTEEL CNRYY AXBA BAJAJFINSV TATASTEEL TATLY 500180 GAILY CANBK 506401 BHRYY 533150 500228 RELIANCE 532617 HINDUNILVR 532978 533155 JUBLFOOD 532215 DEEPAKNI 532221 500470 535648 AXISBANK RIGD JBLWY INFRATEL HDFCBANK GRAVITA YESBANK IBN IDKQY 532648 JPASSOCIAT AXBKY 532532 IBULHSGFIN ICICIBANK GODREJPROP TTST HDB 532174 500049 JSTQY
Mormugao is Goa’s oldest port that is accorded major port status since 1963. Goa has faced some decline in industrial activity after the Supreme Court’s ban on mining since 2012. But the port is still quite relevant in the region. The deputy chairman of Mormugao Port Trust, Guruprasad Rai, who is also acting chairman of the company, outlines the challenges and growth plans of the port. Rai, who has a career spanning nearly three decades, talks to Pankaj Joshi and R N Bhaskar about his vision for the port.
One of the five Jet Airways passengers who were sent to a city hospital for treatment, has demanded Rs 30 lakh in compensation, besides 100 upgrade vouchers, alleging lack of proper care by the airline, sources in the airline have said.
It is a strong start for the Indian stock market this Friday morning with the Nifty50 up 89 points and is trading at 11,323 while the Sensex is trading higher by 294 points at 37,415.
523405 IOC RTI RLTAY 500325 82HP TCHQY PRMQY ASIANPAINT 532755 JUSTDIAL 532483 GAILF BEL JMFINANCIL RLNIY SBAZ BHQRY AXB 524804 532508 JETAIRWAYS YYBKY 530965 JSWSTEEL CNRYY TECHM AXBA TATASTEEL TATLY GAILY 500302 CANBK 506401 500188 HINDZINC 523367 500820 AUROPHARMA 533150 500228 RELIANCE 532617 HNDZY 532215 DEEPAKNI 500470 535648 532461 AXISBANK RIGD JSL YESBANK UBNC HINDALCO IBN 532648 PEL AXBKY HNDNF ICICIBANK GODREJPROP TTST PNJZY 532174 ARBQY 500366 PNB DCMSHRIRAM 500049 ROLTA JSTQY 500440
Shares of Jet Airways touched 52-week low of Rs 224.70, down 8 percent intraday Friday after Income tax investigation department conducted survey on companies premises.
Jet Airways (India) Ltd said it would monetize its 49% stake in Jet Privilege Pvt. Ltd, the frequent-flyer loyalty programme subsidiary. News reports suggest the associate company will be valued at ₹ 3,000-4,000 crore. While Jet Airways’ market capitalisation is about ₹ 3,000 crore, after adding its net debt, the airline’s enterprise value would be at ₹ 10,000 crore. That’s just about 0.4 times its consolidated revenue.
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
New Delhi: More than 13 years ago, a Boeing aircraft crashed in a hilly terrain in Greece snuffing out 121 lives. A year later, investigators concluded that omissions in controlling cabin pressure was a key reason for the crash. On Thursday morning, the 166 passengers on board a Jet Airways flight might not have been aware about the incident that happened in Greece over a decade ago. But, they faced a similar situation as the cockpit crew “forgot” to control cabin pressure.
Mumbai: A consortium of overseas lenders to Jet Airways (India) Ltd may ask the airline to expedite the repayment of loans worth $150 million amid its deteriorating financial health, two people directly aware of the matter said, requesting anonymity. A letter on behalf of the lenders was sent by Dubai-based Mashreq Bank to Jet Airways on Monday seeking a detailed response by 24 September. Mashreq Bank was the arranger to the loan.
ICICIBANK PNJZY 532461 532174 IBN 532617 PNB JETAIRWAYS
2018-09-18 - Asif
Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...
2018-09-18 - Asif
Overview The company design, develop and sell exoskeleton technology to augment human strength, endurance and mobility. The company's exoskeleton technology serves multiple markets and can be used both by able-bodied users as well as by persons with physical disabilities. Ekso Bionics has sold, rented or leased devices that (a) enable individuals with neurological conditions affecting gait (stroke and spinal cord injury) to rehabilitate and to walk again and (b) allow industrial workers to perform heavy duty work for extended periods. Today, its medical exoskeleton, Ekso GT, is used as a rehabilitation tool to allow physicians and therapists to rehabilitate patients who have suffered a stroke or spinal cord injury. With its unique features designed specifically for hospitals and its proprietary SmartAssist software, Ekso GT allows for the early mobilization of patients, with high step count and high dosage treatments. The intent is to allow the patient’s central nervous syst...
2018-09-18 - Asif
Overview Agile Therapeutics is a forward-thinking women’s healthcare company dedicated to fulfilling the unmet health needs of today’s women. Twirla® and its other current potential product candidates are designed to provide women with contraceptive options that offer greater convenience and facilitate compliance. The company's lead product candidate, Twirla, also known as AG200-15, is a once-weekly prescription contraceptive patch that is at the end of Phase 3 clinical development. Since its inception in 1997, Agile Therapeutics has devoted substantial resources to developing Twirla, building its intellectual property portfolio, business planning, raising capital and providing general and administrative support for these operations. The company incurred research and development expenses of $14.4 million, $20.9 million and $25.6 million during the years ended December 31, 2017, 2016 and 2015, respectively. The company incurred research and development expenses of $2.4 milli...